chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine, 3 hours later she had itching under her arm and scratched it and realized she had a lot of bumps.  She also got an intense itching and bumps on her inner upper left arm, before axilla.  It's a T1 dermatome.  She thought it could not get shingles from it, and had 2 friends look at it and confirmed it was shingles.  Friend is a physician and said that he had seen this a few times.  Her is not red but just a little tenderness around the injection site.    She is a physician herself.
pt recv vax 5/19/99 & mom states child vaccine site lt deltoid was red & swollen upon awakening Am 5/20/99;no fever, no apparent discomfort;observe for worsening of swelling or inc in pain or fever;
pt recvd vax;w/in 24 hrs exp a low grade fever 101-102 & a sz;to er;sz described as just staring w/ no involvement of arms or legs; neuro-consult - abnl EEG (spikes);
sore arm; Extreme fatigue; My arms felt like lead for three days; I felt so sleepy/I felt like I could barely keep my eyes open for three days; mild headache; menstrual cramps; diarrhea; I had bizarre dreams like being attacked by zombies for three days; chills; This is a spontaneous report from a contactable pharmacist. A 43-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration at Left arm on 23Dec2020 17:45 at single dose for covid-19 immunization. Patient known allergies included Imitrex, beef, grass, weeds, trees, Cats. Other medical history included Asthma, allergies, migraine, Premenstrual syndrome (PMS), overweight. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine but received other medications in two weeks. The COVID-19 vaccine was administered at Hospital. The patient experienced extreme fatigue. Her arms felt like lead for three days, and she felt so sleepy. She felt like she could barely keep her eyes open for three days. She had a mild headache. It triggered menstrual cramps and diarrhea for three days. She had bizarre dreams like being attacked by zombies for three days. She had chills for a few hours. She had a sore arm for a couple of days. Adverse events start date was 23Dec2020 10:00 PM. Treatment included Tylenol. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. Outcome of chills was recovered on 24Dec2020, of headache, chills, fatigue and sore arm was recovered in Dec2020, of other events was recovered on 26Dec2020.
Vaccine was stored on refrigerator on 22-Aug-2022 and vaccine was administered on 23-Sep-2022; No Adverse event; patient given vaccine after BUD date, expire beyond date 22-Sep-2022, vaccine administered 23-Sep-2022; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient given vaccine after BUD date, expire beyond date 22-Sep-2022, vaccine administered 23-Sep-2022), PRODUCT STORAGE ERROR (Vaccine was stored on refrigerator on 22-Aug-2022 and vaccine was administered on 23-Sep-2022) and NO ADVERSE EVENT (No Adverse event) in a 1-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9237B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Sep-2022 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Sep-2022 at 4:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient given vaccine after BUD date, expire beyond date 22-Sep-2022, vaccine administered 23-Sep-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored on refrigerator on 22-Aug-2022 and vaccine was administered on 23-Sep-2022) and NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient given vaccine after BUD date, expire beyond date 22-Sep-2022, vaccine administered 23-Sep-2022), PRODUCT STORAGE ERROR (Vaccine was stored on refrigerator on 22-Aug-2022 and vaccine was administered on 23-Sep-2022) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient given vaccine after BUD date, expire beyond date 22-Sep-2022, vaccine administered 23-Sep-2022) and PRODUCT STORAGE ERROR (Vaccine was stored on refrigerator on 22-Aug-2022 and vaccine was administered on 23-Sep-2022).    Concomitant product use was not provided by the reporter.  It was reported vaccine was not gone under any temperature excursion.  Treatment information was not provided.
Detected afib the morning  by taking my pulse after the Pfizer shot #2. Treated by cardioversion #9.
Inflamed large, red area at injection site. worsened next day. pt worried about tissue damage.
Woke up at 1:00 am with extremely rapid heart beat?130 bpm. It did not subside so I contacted the pharmacy who suggested I notify my doctor. I visited his office at 2:00 pm. He ran an EKG. It was normal so gave me a prescription for a beta blocker. After taking that, my heart rate returned to normal. I also had a slight fever, body aches & headache.
This case was reported by a physician via a sales representative and described the occurrence of bump at injection site for 8 months in a 2-year-old subject of unspecified gender who was vaccinated with INFANRIX (GlaxoSmithKline). In March 2009 2009 the subject received unspecified dose of INFANRIX (unknown). At an unspecified time after vaccination with INFANRIX time after vaccination with INFANRIX, the subject experienced bump at injection site for 8 months, a preliminary biopsy was positive for aluminum, possible allergy to aluminum, and drug dose administration interval too long. At the time of reporting  the outcome of the events was unspecified. On 16 October 2009, a physician reported via a sales representative that a subject experienced a bump at injection site for 8 months. The preliminary biopsy was positive for aluminum. The subject may have had an aluminum allergy. The date of injection was March 2009. This was a catch-up vaccine. The sales representative had no additional information to provide. The subject's bump at the injection site was also described as itchy. The subject was diagnostic with local allergic reaction. Follow up information was provided on 11 November 2009 via the vaccine responsible physician. On an unspecified date in March 2009, the subject received a fourth dose of INFANRIX (intramuscularly, right thigh). The physician reported the onset date of the previously reported events was on 15 May 2009, ,approximately two months after vaccination with INFANRIX. The physician reported the immunization series was delayed due to parent's choice. The physician reported that a biopsy was performed; however, the physician did not have the biopsy results since it was "done elsewhere". At the time of reporting, the outcome of the events was unresolved.
pt recv vax;PC fr mom stating pt adm to med ctr for sz;mom thinks vax caused sz;
Experiencing a very sore arm and it is hard to lift it and  it is just sore, real sore/I can hardly raise my arm and it hurts; Experiencing a very sore arm and it is hard to lift it and  it is just sore, real sore/I can hardly raise my arm and it hurts; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 73-year-old female patient received bnt162b2 (BNT162B2), administration date 02Mar2021 11:20 (Batch/Lot number: unknown) at the age of 73 years as dose 2, single for covid-19 immunization.   The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), for Covid-19 Immunization.  The following information was reported: PAIN IN EXTREMITY (non-serious), MOBILITY DECREASED (non-serious) all with onset 03Mar2021, outcome "unknown" and all described as "Experiencing a very sore arm and it is hard to lift it and it is just sore, real sore/I can hardly raise my arm and it hurts". Therapeutic measures were not taken as a result of pain in extremity, mobility decreased.  Additional information: the patient wanted to know was it was a natural effect of the shot. She mentioned that the first one was fine and after the second one when she noticed it was sore. Consumer stated that she did not receive any treatment. She just hoped that it would go away. Comment: This case might be spilt since further clarifications about husband was unknown, hence split not made.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient called pharmacy stating she had swollen arm, trouble breathing, lips tingling, and tight throat. Primary care provider contacted. Patient was recommended to go in. She later was taken by ambulance and treated in ER.
an hr p/receiving vax began to feel sick & nauseous went home @ 5PM & went to bed feeling dizzy, & nauseous vomited several times throughout noc; contacted MD next AM but MD out of office; bones hurt;
10/5/2022 A CBC blood test performed.  Flagged as a low blood platelet count.  On 12/9, PCP reran blood work and recommended stopping Low Dose aspirin.  Platelet Count was down to 11,000.  PCP referred to Hematologist and prescribed a 4-day steroid treatment.  Hematologist was seen on 12/19 and discovered the platelet count 56,000.  Hematologist performed an abdominal ultrasound, nothing of concern revealed.  Treatment process ongoing.
Persistent Right arm tennis elbow; Increased pain on movement/Pain from back of elbow to top of forearm; Increased pain on movement/Pain from back of elbow to top of forearm; This is a spontaneous report from a contactable nurse (patient self). A 50-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: ELO140), via an unspecified route of administration on 19Dec2020 11:00 at single dose on right arm for COVID-19 immunisation. Medical history included hypothyroidism and known allergies: sulfa drugs and clarithromycin (MACROBID). Concomitant medications included bupropion hydrochloride (WELLBUTRIN), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), estradiol (ESTROGEN), testosterone and progesterone (PROGESTON [PROGESTERONE]). The patient experienced persistent right arm tennis elbow. Increased pain on movement. Pain from back of elbow to top of forearm on 21Dec2020 08:00 with outcome of not recovered. No treatment was received for the events. Patient received 2nd dose of bnt162b2 (lot: ELO140) on 09Jan2021 on left arm.
Information regarding PREVNAR was received from a healthcare professional regarding a 6-month-old male patient who experienced injection site swelling and fever. At 6 months of age, the patient received the third dose on 03-Feb-2009. The patient also received a dose of TRIPACEL (Adventis-Pasteur), a dose of polio vaccine "Pasteur" and a dose of HIBEST (Pasteur vaccines) (haemophilus b conjugate vaccine (tetanus) on 03-Feb-2009. The patient experienced injection site swelling and fever on 04-Feb-2009. The outcome of the events is unknown. No additional information was available at the time of this report. Follow-up information provided event outcomes. The patient experienced injection site swelling and fever on 04-Feb-2009. The patient recovered. No additional information was available at the time of this report.
Patient admitted to hospital evening of 2/7/21 with acute ischemic stroke and received tenectaplase.  Diagnosis Left MCA stroke.  Reporting event given was just over 24 hours after first COVID vaccine dose.
no documented react; only complaint from mom & hlth clinic notified us; unable to reach mom for further info;
Rt arm vaccine site still sore and hurts. Arm still hurts. Con to lay on rt side.
This spontaneous report was received from a nurse refers to a patient of unknown age. On 23-JAN-2014, the patient was vaccinated with a dose of VAQTA, 1 ml, intramuscular. The nurse reported that the patient received a second dose of VAQTA, too early at 5 weeks after her first dose and no adverse effects reported. Additional information has been requested.
Initial unsolicited report received from other non-healthcare professional on 13 April 2017. This case involves a 29-year-old male patient who was vaccinated with dose of YELLOW FEVER VACCINE (Batch number:172VFA0072, expiry date, dose, route and site of administration were not reported) on 10 April 2017. Patient's illness at the time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions were unknown. Concomitant medication was not reported. On 12 April 2017, two days following the vaccination, patient had fever, shaking, diarrhea, tiredness and muscle weakness. Laboratory investigation and corrective treatment were not reported. Patient was not recovered from events. List of documents held by sender: none.
pt recv vax & w/in 15min post vax pt exp runny nose, sneezing & an insecticide taste in mouth & n/v & began to feel numbness in chest;also SOB & itching & shivering cold;
Started feeling sick immediately post vaccination - developed nausea, vomiting, diarrhea, weakness x 2 weeks.
Patient reports that after a couple of hours when she received the shot she experienced itchy watery eyes, fever and vomiting. Was hospitalized x 3 days.
after booster shoot she started experiencing inflammation in all her joints all over the body.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Dec-2021 and was forwarded to Moderna on 26-Dec-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (after booster shoot she started experiencing inflammation in all her joints all over the body.) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 077C21B) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (after booster shoot she started experiencing inflammation in all her joints all over the body.). At the time of the report, ARTHRITIS (after booster shoot she started experiencing inflammation in all her joints all over the body.) outcome was unknown.            Reporter states that concomitant medication includes blood pressure medication for high blood medication. Reporter states that treatment medication includes steroid medication.; Sender's Comments: This is a spontaneous case received from an unknown source, reported by a consumer, concerns a 81 year old elderly female with  no relevant medical history, who experienced the unexpected non serious AESI of Polyarthritis, after the booster dose of mRNA-1273 vaccine given on 11 Nov 2021 . The route of administration, dose of the vaccine , onset date and time of the event was not reported. As per the reporter, after the booster shot, she started experiencing inflammation in all her joints all over the body. Concomitant medications included Blood pressure medications. Steroids were given as treatment medications for the event. The outcome of the event was not reported. The reporter did not provide any causality assessment for the event. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
Body tremors, feeling cold, tiredness, dizziness, headache, rapid heart beat, injection site pain.
Severe muscle pain, chills, headache, nausea.  Chills and nausea lasted about 4 hours but the headache and muscle pain are still on going at the 9 hour mark.
Extreme anxiety and depression; Extreme anxiety and depression; This is a spontaneous report from a contactable consumer (patient). A 37-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in arm right on 16Feb2021 17:00 (Batch/Lot number was not reported) as 2ND DOSE, SINGLE for COVID-19 immunization. The patient medical history included ear infection. Patient had no known allergies. Concomitant medication included hydrocortisone, neomycin sulfate, polymyxin b sulfate (ANTIBIOTIC EAR) taken for ear infection. The patient was not diagnosed with COVID-19 prior to vaccination. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. The patient experienced extreme anxiety and depression on 16Feb2021. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was hospitalized for the events for 1 day. Therapeutic measures were taken as the result of the events which included treatment with anti-anxiety depression meds. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Fussy the night of shots, woke in the am with redness at 3 sites (size of a nickel x 2; size of dime x 1).
Patient vaccinated with COVID-19 vaccines and admitted to hospital for COVID-19 symptoms.  Patient admitted for hypoxia and pneumonia due to COVID-19.
pt recv vax 21NOV96 & 4DEC96 pt devel a mild case of chicken pox;
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 58-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication reported.
Within half hour of receiving COVID vaccine, patient developed headache, then began feeling lightheaded and began pale. Attempted to lay down, upon standing felt lightheaded and noted some numbness around her lips, arms, and legs. Symptoms include faintness, near syncope, and numbness. After about 10-15 minutes of not feeling well, patient was escorted to the Emergency Room. Patient received fluids and was discharged home. Patient reports at 5pm that she continues to have slight headache and arm soreness with no further near syncopal episodes.
redness, ecchymosis to surrounding areas 2-3cm diameter small palp nodule <5mm. -appear tid. On Antibiotics.
I had a few pains  on my left  side near bottom  of breast , then an aching pain that went  to my back. I have not had this symptom  since  Wednesday
Pt has had 2.5 inch by 2 inch redness surrounding injection site with slightly hard center. Pain in arm and headache, feeling tired 8-12-2020. Less pain today.
Fridge temp out of range 1-9-17. No adverse reaction. Re-vax recommended: ROTATEQ only.
Patient of 1 YO received Kinrix; received Kinrix instead of receiving DTAP and IPV separately; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old female patient who received DTPa-IPV (Kinrix) (batch number 24t2N, expiry date 7th May 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date:18-May-2022 Reporter's comments: Nurse practitioner reported that few months ago the patient of 1year age received Kinrix instead of receiving DTAP and IPV separately. The consent to follow up was given.  Additional Supportive Information: The 1 year old patient received Kinrix instead of receiving DTAP and IPV separately, which led to inappropriate age at vaccine administration and wrong vaccine administered.
A report has been received from health professional via medical rep concerning a male patient. No information regarding relevant history and concomitant medication was provided. Reporter stated that she gave patient a dose of the FLUMIST Quadrivalent (Intranasal). After that he had an exacerbation of his asthma for about 1 week. Doctor was contemplating whether patient should get the FLUMIST vaccine again next year. Action taken with FLUMIST Quadrivalent was unknown. The outcome of exacerbation of asthma was unknown. The company physician assessed exacerbation of asthma to be non-serious.
Information has been received from an immunization official healthcare worker referring to multiple unspecified patients of unknown age and gender. On an unknown date the patients were vaccinated with ROTATEQ (dose, frequency, and lot# were not reported), which were stored improperly. No adverse effects were reported. This is one of three reports received from the same source. Additional information has been requested.